Floatz logo

compound solution of sodium chloride

Lung Cancer

Cukurova UniversitymixtureN/AActive
D
28/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
65/ 100

Competitive context

222 Active assets in the Lung Cancer cohort.

Asset / SponsorPhaseRating
Carboplatin
SystImmune Inc.
Phase 4BB
CIS-DIAMMINEDICHLOROPLATINUM II
University of Vermont
Phase 4BB
Nivolumab
University of Chicago
Phase 4BB
ETOPOSIDE
SystImmune Inc.
Phase 3BB
Irinotecan
City of Hope Medical Center
Phase 3BB

View all 50 →

Same molecule, other indications

compound solution of sodium chloride is also rated in:

hemorrhagic strokeDormant
B
Indicative ·
62 / 100
View asset →
infectious disease with sepsisDormant
B
Indicative ·
61 / 100
View asset →
Blood Loss, SurgicalDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →